Safety Features
Latex protein no more than 50μg of protein per gram and dm², eliminates risk of Latex Allergy - Type 1.
Chemical residue almost nil, eliminates risk of Contact Dermatitis - Type IV Allergy.
Absence of powder eliminates dangers associated with powder, preventing granulomas, adhesions, fibrosis and occupational asthma. Does not contaminate sterile work area.
Latex film structure passes Viral Penetration Test (ASTM F1671:2013)
Manufactured in clean environment to reduce bio-burden level prior to sterilization. This achieves low Pyrogen level after sterilization.
Manufactured in a clean environment to comply with EN 556 & ISO 13485 requirements.
Sterilized in a validated process cycle to achieve sterility assurance level of 10⁻⁶, and air wash cycles to reduce sterilant residue to less than 4mg/unit.